Brind.

Exact Sciences could benefit from Trump-era tariffs, with Jefferies reiterating a Buy rating on the company.

1 report, 1 independent Updated Aug 31

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Exact Sciences Donald Trump

Keep exploring

The entities involved

Exact Sciences
American company in Madison, United States

Nothing else this week.
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
- Abdul El-Sayed won the Michigan Senate primary and is now facing political challenges, including criticism from Donald Trump and discussions about potential support from Barack Obama.Sun 23:57
- Trump, Hegseth, and Bessent discuss threats and escalation against Iranian targets in the Strait of Hormuz.Sun 23:56

Coverage

Newest first; wire copies grouped

Aug 31Insider MonkeyJefferies Reiterates a Buy Rating on Exact Sciences Corporation (EXAS) Exact Sciences Corporation (NASDAQ:EXAS) is one of the best strong buy growth stocks to buy now. On August 21, Jefferies analyst